PCN Insights, News, Videos, and More
News
08/09/2023
Aerobic-resistance exercise and computerized cognitive training could improve cognition in older adults with mild cognitive impairment, according to a randomized clinical trial published in JAMA Network Open.
Aerobic-resistance exercise and computerized cognitive training could improve cognition in older adults with mild cognitive impairment, according to a randomized clinical trial published in JAMA Network Open.
Aerobic-resistance exercise and...
08/09/2023
Neurology
News
08/08/2023
Tom Valentino, Digital Managing Editor
The guidelines—a first for psychedelic-assisted therapy—were developed by a working group of leaders in the field from multiple disciplines to set benchmarks informed by clinical research and industry expert consensus.
The guidelines—a first for psychedelic-assisted therapy—were developed by a working group of leaders in the field from multiple disciplines to set benchmarks informed by clinical research and industry expert consensus.
The guidelines—a first for...
08/08/2023
Psych Congress Network
Videos
08/08/2023
Greg Mattingly, MD, discusses new mechanisms on the horizon for MDD
Greg Mattingly, MD, discusses new mechanisms on the horizon for MDD
Greg Mattingly, MD, discusses...
08/08/2023
Psych Congress Network
Videos
08/07/2023
Featuring Vladimir Maletic, MD, MS
Featuring Vladimir Maletic, MD, MS
...
Vladimir Maletic MD, MS, discusses his case presentation "Navigating Setbacks to School: A Complex Pediatric Case Study."
Vladimir Maletic MD, MS, discusses his case presentation "Navigating Setbacks to School: A Complex Pediatric Case Study."
Vladimir Maletic MD, MS,...
08/07/2023
Psych Congress Network
News
08/07/2023
The FDA approved Zurzuvae (zuranolone) on Friday through a fast-track designation, making it the first oral medication designed for the treatment of PPD in adults.
The FDA approved Zurzuvae (zuranolone) on Friday through a fast-track designation, making it the first oral medication designed for the treatment of PPD in adults.
The FDA approved Zurzuvae...
08/07/2023
Psych Congress Network
Videos
08/06/2023
Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.
Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.
Ahmed Baig, MD, Chief Medical...
08/06/2023
Psych Congress Network
Videos
08/05/2023
With Greg Mattingly, MD, and Elizabeth Judd, NP, MHS
With Greg Mattingly, MD, and Elizabet...
Dr Mattingly and Nurse Judd discuss the complexities of ADHD diagnosis.
Dr Mattingly and Nurse Judd discuss the complexities of ADHD diagnosis.
Dr Mattingly and Nurse Judd...
08/05/2023
Psych Congress Network
Videos
08/03/2023
Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.
Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.
Ahmed Baig, MD, Chief Medical...
08/03/2023
Psych Congress Network
Podcasts
08/03/2023
With Amber Hoberg, MSN, APRN, PMHNP-BC, and Saundra Jain, MA, PSYD, LPC
With Amber Hoberg, MSN, APRN, PMHNP-B...
Nurse Hoberg sheds light on rare presentations of movement disorders as well as in-person and virtual treatment challenges.
Nurse Hoberg sheds light on rare presentations of movement disorders as well as in-person and virtual treatment challenges.
Nurse Hoberg sheds light on rare...
08/03/2023
Psych Congress Network
News
08/02/2023
Women with ADHD were found to have a harder time with social functioning and feel a sense of relief following their diagnosis, according to a systematic review and meta-analysis published in the Journal of Attention Disorders.
Women with ADHD were found to have a harder time with social functioning and feel a sense of relief following their diagnosis, according to a systematic review and meta-analysis published in the Journal of Attention Disorders.
Women with ADHD were found to...
08/02/2023
Psych Congress Network
